Exploring Potential Mechanisms of Insect-Derived Drugs in Treating Atrial Fibrillation Based on Data Mining, Network Pharmacology and Molecular Docking Techniques
This study uses data mining, network pharmacology, and molecular docking to explore the potential mechanisms of insect-derived traditional Chinese medicines against atrial fibrillation (AF). We systematically screened 11 insect-derived medicines from multiple databases and identified 49 active compounds targeting 1038 unique genes. Cross-analysis with 645 known AF-related targets revealed 61 common targets. Key pathways involved include arrhythmogenic right ventricular cardiomyopathy and atherosclerosis. Molecular docking confirmed strong binding between core compounds (e.g., ergotamine) and targets (e.g., CACNA1C). Our findings suggest that these drugs exert anti-AF effects through multi-component, multi-target, and multi-pathway mechanisms, providing novel insights into their potential clinical applications.
References
[1]
Brundel, B.J.J.M., Ai, X., Hills, M.T., Kuipers, M.F., Lip, G.Y.H. and de Groot, N.M.S. (2022) Atrial Fibrillation. NatureReviewsDiseasePrimers, 8, Article No. 21. https://doi.org/10.1038/s41572-022-00347-9
[2]
Cheng, S., He, J., Han, Y., Han, S., Li, P., Liao, H., etal. (2024) Global Burden of Atrial Fibrillation/Atrial Flutter and Its Attributable Risk Factors from 1990 to 2021. Europace, 26, euae195. https://doi.org/10.1093/europace/euae195
[3]
Shi, S., Tang, Y., Zhao, Q., Yan, H., Yu, B., Zheng, Q., etal. (2022) Prevalence and Risk of Atrial Fibrillation in China: A National Cross-Sectional Epidemiological Study. TheLancetRegionalHealth-WesternPacific, 23, Article 100439. https://doi.org/10.1016/j.lanwpc.2022.100439
[4]
Joglar, J.A., Chung, M.K., Armbruster, A.L., Benjamin, E.J., Chyou, J.Y., Cronin, E.M., etal. (2024) 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149, e1-e156. https://doi.org/10.1161/cir.0000000000001193
[5]
Morseth, B., Geelhoed, B., Linneberg, A., Johansson, L., Kuulasmaa, K., Salomaa, V., etal. (2021) Age-Specific Atrial Fibrillation Incidence, Attributable Risk Factors and Risk of Stroke and Mortality: Results from the MORGAM Consortium. OpenHeart, 8, e001624. https://doi.org/10.1136/openhrt-2021-001624
[6]
Ninni, S., Dombrowicz, D., de Winther, M., Staels, B., Montaigne, D. and Nattel, S. (2024) Genetic Factors Altering Immune Responses in Atrial Fibrillation. JournaloftheAmericanCollegeofCardiology, 83, 1163-1176. https://doi.org/10.1016/j.jacc.2023.12.034
Reddy, V.Y., Gerstenfeld, E.P., Schmidt, B., Nair, D., Natale, A., Saliba, W., etal. (2025) Pulsed Field Ablation for Persistent Atrial Fibrillation. JournaloftheAmericanCollegeofCardiology, 85, 1664-1678. https://doi.org/10.1016/j.jacc.2025.03.515
[9]
Ye, T.-S. (2017) A Guide to Clinical Case Studies. People’s Medical Publishing House.
[10]
Wang, F. (2015) An Exploration of the Origins of Medical Compilations. In: Jiang, L.-Z., Ed., ChinaPressofTraditionalChineseMedicine, 123-125.
[11]
Tao, H.-J. (2013) Supplementary Records of Renowned Physicians: A Collated Edition. China Press of Traditional Chinese Medicine.
[12]
Lian, X., Liu, B., Li, D., Wang, X., Long, C., Feng, X., etal. (2025) An Elastase Inhibitor ShSPI from Centipede Attenuates Bleomycin-Induced Pulmonary Fibrosis. Toxins, 17, Article 213. https://doi.org/10.3390/toxins17050213
[13]
Lu, W., Cheng, X., Chen, J., Wang, M., Chen, Y., Liu, J., etal. (2021) A Buthus Martensii Karsch Scorpion Sting Targets Nav1.7 in Mice and Mimics a Phenotype of Human Chronic Pain. Pain, 163, e202-e214. https://doi.org/10.1097/j.pain.0000000000002397
[14]
Luo, T., Lu, Y., Yan, S., Xiao, X., Rong, X. and Guo, J. (2020) Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective. ChineseJournalofIntegrativeMedicine, 26, 72-80. https://doi.org/10.1007/s11655-019-3064-0
[15]
Paggi, J.M., Pandit, A. and Dror, R.O. (2024) The Art and Science of Molecular Docking. AnnualReviewofBiochemistry, 93, 389-410. https://doi.org/10.1146/annurev-biochem-030222-120000
[16]
National Pharmacopoeia Commission (2020) Pharmacopoeia of the People’s Republic of China: Volume I. China Medical Science Press.
[17]
State Administration of Traditional Chinese Medicine (1999) Zhong Hua Ben Cao: Volume 1. Shanghai Science and Technology Press.
[18]
Heijman, J., Voigt, N., Nattel, S. and Dobrev, D. (2014) Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression. CirculationResearch, 114, 1483-1499. https://doi.org/10.1161/circresaha.114.302226
[19]
Pikunov, A.V., Syunyaev, R.A., Ali, R., Prakosa, A., Gams, A., Boyle, P.M., etal. (2025) Role of Structural versus Cellular Remodeling in Atrial Arrhythmogenesis: Insights from Personalized Digital Twins. Circulation: ArrhythmiaandElectrophysiology, 18, e013898. https://doi.org/10.1161/circep.125.013898
[20]
Meng, S., Huang, T., Zhou, Z., Yu, L. and Wang, H. (2025) Chronic Mild Stress Exacerbates Atrial Fibrillation and Neutrophil Extracellular Traps Formation through S100A8/A9 Signaling. SignalTransductionandTargetedTherapy, 10, Article No. 108. https://doi.org/10.1038/s41392-025-02199-7
[21]
Chen, M., Zhang, X.P., Fan, Y.Y. and Zhang, M.S. (2016) Mannitol Preconditioning Alleviates Hypoxia/Reoxygenation Injury in H9c2 Cells. ChineseJournalofClinicalPharmacology, 32, 1011-1013.
[22]
Magovern, G.J., Bolling, S.F., Casale, A.S., Bulkley, B.H. and Gardner, T.J. (1984) The Mechanism of Mannitol in Reducing Ischemic Injury: Hyperosmolarity or Hydroxyl Scavenger? Circulation, 70, I91-I95.
[23]
Feige, K., Rubbert, J., Raupach, A., Stroethoff, M., Heinen, A., Hollmann, M.W., etal. (2021) Cardioprotective Properties of Mannitol—Involvement of Mitochondrial Potassium Channels. InternationalJournalofMolecularSciences, 22, Article 2395. https://doi.org/10.3390/ijms22052395
[24]
Ozcan, C., LI, Z., Kim, G., Jeevanandam, V. and Uriel, N. (2019) Molecular Mechanism of the Association between Atrial Fibrillation and Heart Failure Includes Energy Metabolic Dysregulation Due to Mitochondrial Dysfunction. JournalofCardiacFailure, 25, 911-920. https://doi.org/10.1016/j.cardfail.2019.08.005
[25]
Mauriello, A., Correra, A., Molinari, R., Del Vecchio, G.E., Tessitore, V., D’Andrea, A., etal. (2024) Mitochondrial Dysfunction in Atrial Fibrillation: The Need for a Strong Pharmacological Approach. Biomedicines, 12, Article 2720. https://doi.org/10.3390/biomedicines12122720
[26]
Asdaq, S.M.B. and Inamdar, M.N. (2010) Potential of Crocus Sativus (Saffron) and Its Constituent, Crocin, as Hypolipidemic and Antioxidant in Rats. AppliedBiochemistryandBiotechnology, 162, 358-372. https://doi.org/10.1007/s12010-009-8740-7
[27]
Yu, L., Gao, R., Song, X., Li, X. and Zhu, J. (2021) Cardio-Protective and Anti-Atherosclerosis Effect of Crocetin on Vitamin D3 and HFD-Induced Atherosclerosis in Rats. JournalofOleoScience, 70, 1447-1459. https://doi.org/10.5650/jos.ess21168
[28]
Su, X., Yuan, C., Wang, L., Chen, R., Li, X., Zhang, Y., etal. (2021) The Beneficial Effects of Saffron Extract on Potential Oxidative Stress in Cardiovascular Diseases. OxidativeMedicineandCellularLongevity, 2021, Article ID: 6699821. https://doi.org/10.1155/2021/6699821
[29]
Higashino, S., Sasaki, Y., Giddings, J.C., Hyodo, K., Fujimoto Sakata, S., Matsuda, K., etal. (2014) Crocetin, a Carotenoid from Gardenia jasminoides Ellis, Protects against Hypertension and Cerebral Thrombogenesis in Stroke‐prone Spontaneously Hypertensive Rats. PhytotherapyResearch, 28, 1315-1319. https://doi.org/10.1002/ptr.5130
[30]
Cai, J., Yi, F., Bian, Z., Shen, D., Yang, L., Yan, L., etal. (2009) Crocetin Protects against Cardiac Hypertrophy by Blocking MEK‐ERK1/2 Signalling Pathway. JournalofCellularandMolecularMedicine, 13, 909-925. https://doi.org/10.1111/j.1582-4934.2008.00620.x
[31]
Gomes, A.R., Varela, C.L., Pires, A.S., Tavares-da-Silva, E.J. and Roleira, F.M.F. (2023) Synthetic and Natural Guanidine Derivatives as Antitumor and Antimicrobial Agents: A Review. BioorganicChemistry, 138, Article 106600. https://doi.org/10.1016/j.bioorg.2023.106600
[32]
Dambrova, M., Veveris, M., Cirule, H., Pugovichs, O., Post, C., Lundstedt, T., etal. (2002) The Novel Guanidine ME10092 Protects the Heart during Ischemia-Reperfusion. EuropeanJournalofPharmacology, 445, 105-113. https://doi.org/10.1016/s0014-2999(02)01596-0
[33]
Roh, H., Jung, I., Park, J., Yun, Y., Yi, K., Yoo, S., etal. (2005) Cardioprotective Effects of [5-(2-Methyl-5-Fluorophenyl)Furan-2-Ylcarbonyl]Guanidine (KR-32568) in an Anesthetized Rat Model of Ischemia and Reperfusion Heart Injury. Pharmacology, 75, 37-44. https://doi.org/10.1159/000086192
[34]
Hussey, J.W., Limpitikul, W.B. and Dick, I.E. (2023) Calmodulin Mutations in Human Disease. Channels, 17, Article 2165278. https://doi.org/10.1080/19336950.2023.2165278
[35]
Chang, Y. and Zou, Q. (2025) Mitochondrial Calcium Homeostasis and Atrial Fibrillation: Mechanisms and Therapeutic Strategies Review. CurrentProblemsinCardiology, 50, Article 102988. https://doi.org/10.1016/j.cpcardiol.2025.102988
[36]
Walweel, K., Gomez-Hurtado, N., Rebbeck, R.T., Oo, Y.W., Beard, N.A., Molenaar, P., etal. (2019) Calmodulin Inhibition of Human RyR2 Channels Requires Phosphorylation of RyR2-S2808 or RyR2-S2814. JournalofMolecularandCellularCardiology, 130, 96-106. https://doi.org/10.1016/j.yjmcc.2019.03.018
[37]
Wehrens, X.H.T., Lehnart, S.E., Reiken, S., Vest, J.A., Wronska, A. and Marks, A.R. (2006) Ryanodine Receptor/Calcium Release Channel PKA Phosphorylation: A Critical Mediator of Heart Failure Progression. ProceedingsoftheNationalAcademyofSciences, 103, 511-518. https://doi.org/10.1073/pnas.0510113103
[38]
Ronkainen, J.J., Hänninen, S.L., Korhonen, T., Koivumäki, J.T., Skoumal, R., Rautio, S., etal. (2011) Ca2+-Calmodulin‐Dependent Protein Kinase II Represses Cardiac Transcription of the L‐Type Calcium Channel α1C‐Subunit Gene (Cacna1c) by DREAM Translocation. TheJournalofPhysiology, 589, 2669-2686. https://doi.org/10.1113/jphysiol.2010.201400
[39]
Sato, D., Ghayoumi, B., Fasoli, A., Ko, C.Y. and Bers, D.M. (2025) Positive Feedback between RyR Phosphorylation and Ca2+ Leak Promotes Heterogeneous Ca2+ Release. BiophysicalJournal, 124, 717-721. https://doi.org/10.1016/j.bpj.2025.01.023
[40]
Huang, H., Zhao, J., Barrane, F., Champagne, J. and Chahine, M. (2006) NAV1.5/R1193Q Polymorphism Is Associated with Both Long QT and Brugada Syndromes. CanadianJournalofCardiology, 22, 309-313. https://doi.org/10.1016/s0828-282x(06)70915-1
[41]
Kittana, N. (2025) Calcium Signaling in Cardiac Fibroblasts: Roles in Fibrosis and Therapeutic Implications. CardiovascularDrugsandTherapy. https://doi.org/10.1007/s10557-025-07699-w
[42]
Sinagra, G., Cappelletto, C., DE Luca, A., Romani, S., Paldino, A., Korcova, R., etal. (2020) Focus on Arrhythmogenic Right Ventricular Cardiomyopathy. EuropeanHeartJournalSupplements, 22, L129-L135. https://doi.org/10.1093/eurheartj/suaa152
[43]
Zhang, Q.H., Deng, C.Y., Rao, F., Liu, X.Y., Mai, L.P., Zhu, J.N., etal. (2013) Down-Regulation of Desmosomal Gene Expression Impairs Nav1.5 Function in HL-1 Cardiomyocytes. JournalofSouthernMedicalUniversity, 33, 983-989.
[44]
Dridi, H., Kushnir, A., Zalk, R., Yuan, Q., Melville, Z. and Marks, A.R. (2020) Intracellular Calcium Leak in Heart Failure and Atrial Fibrillation: A Unifying Mechanism and Therapeutic Target. NatureReviewsCardiology, 17, 732-747. https://doi.org/10.1038/s41569-020-0394-8
[45]
Landstrom, A.P., Dobrev, D. and Wehrens, X.H.T. (2017) Calcium Signaling and Cardiac Arrhythmias. CirculationResearch, 120, 1969-1993. https://doi.org/10.1161/circresaha.117.310083
